chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable consumer reporting for self.   A 45-years-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in left arm, on 19Mar2021 13:15 (Batch/Lot Number: EP7534) as a single dose (at the age for 45-years-old) for COVID-19 immunisation.  Medical history included asthma and allergies.  The patient did not receive other vaccines in the 4 weeks prior. She received an unspecified concomitant medication for allergy in the two weeks prior. The patient had not experienced COVID prior to vaccination. On22Mar2021, chills and headache started. On 23Mar2021, chills and headache continued and the patient experienced 102 fever with a little cough. She went to the Urgent Care and they diagnosed it as a side effect of the vaccine. On 01Apr2021, the coughing got worse and it turned into pneumonia. On 10Apr2021, she was admitted to the ER for over 103F fever, chills, cough, and shortness of breath. "Low immune from pneumonia developed or flared up the Valley Fever."  The events were treated with steroid shot, antibiotic IVs, fluid IV, and more. The patient was COVID-tested post vaccination with Rapid COVID test (nasal swab) on 25Mar2021 with Negative result, and with PCR test (nasal swab) on 10Apr2021 with negative result. The outcome of the events was not recovered.
Nausea/Vomiting, stuttering, unresponsive to verbal and sternal rub, epi administer and 25 mg diphenhydramine IM. Become responsive and taken out via ambulance.
Experienced severe leg pain for several days. Ultrasound in ER revealed right calf DVT. Prescribed 21 day regimen of Xarelto starting yesterday.
pt recvd vax & devel fever w/ t 100 & blotchy rash over most of body; 13sep rash gone;
gave an expired vaccine; This case was reported by a other health professional via interactive digital media and described the occurrence of expired vaccine used in a patient who received HBV (Engerix B) (batch number 2224M, expiry date 10th March 2022) for prophylaxis.   On 18th March 2022, the patient received Engerix B. On 18th March 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the nurse accidently gave an expired vaccine to the patient, the vaccine expired on 10th March 2022, which led to expired vaccine used. The follow-up would not possible as no contact details were available.
Fatigue, headache, chest pains, side pains, stomach cramps, ovary aches, high blood pressure
Vaccine administration error:  Received 1st covid vaccine on 4/30/2021, Pfizer ; however a sticker for Moderna had been placed on the patient's vaccination card and when she presented today for her vaccine, she told me that she had been scheduled for  Pfizer but she should have Moderna because that is what she had received the first dose . Upon checking her card , I gave her Moderna . When documenting, i realized the error . The patient received 1st dose Pfizer and 2 nd dose Moderna. Pharmacy and patient notified, no immediate adverse reactions noted from vaccination.
Next morning had severe diarrhea. Also leg stiffness, fatigue. This persisted for over a month until I finally went to my primary care. I have seen my gastro and infectious disease in NYC.
nausea; upper back ache; pain at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Feb2021 03:40 (Lot number: EN6202) at the age of 51 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL taken for hypertension (ongoing); AMLODIPINE BESYLATE taken for hypertension (ongoing). The following information was reported: NAUSEA (non-serious) with onset 04Mar2021, outcome "recovered" (04Mar2021), described as "nausea"; VACCINATION SITE PAIN (non-serious) with onset 21Feb2021, outcome "recovered" (22Feb2021), described as "pain at the injection site"; BACK PAIN (non-serious) with onset 02Mar2021, outcome "recovered with sequelae" (04Mar2021), described as "upper back ache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of back pain.  Additional information: Patient didn't reported any Prior Vaccinations (within 4 weeks). AE(s) following prior vaccinations was not reported. Patient's did not have any Medical History and Family Medical History Relevant to AE. Metoprolol: Has been taking for about 5 years. Amlodipine Besylate: Caller has been taking for 5 years. Patient still had a little pain. Patient started taking Tylenol pain killer for her back ache. Patient had a flu shot back in Aug. Supplemental Vaccination Form. History of all previous immunization with the Pfizer vaccine considered as suspect was none Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Family Medical History Relevant to AE no  No follow-up attempts are possible. No further information is expected.
I received the vaccine on 1/20/21 at 2pm.  At 10pm, my right arm was sore, and my temp was 100.8.  I woke up at 12:30 am feeling very hot, temp at that time was 105.3, with body aches, chills, and an excruciating headache.  At 1:30 am it was 103.1, 3:30 am 100.7 after taking Tylenol and Ibuprofen.  By 7am it was down to 98.9.  At 1100 am it was 99.2.  I continued alternating Tylenol with Ibuprofen throughout the entire day.  At 12:50 pm it was 100.8, and I could feel it spike up again around 4pm, although I did not take my temp.  I took Tylenol at that time, temp 99.7 at 5:30pm.  I continued with body aches, and a severe headache that entire next day.  All symptoms with exception of sore arm were gone on 1/22/21
injection site reddened, joint pains, chills, feverish but no fever.  Lasting about 15 hours.  Getting better.  Odd that it's 10 days after the date of vaccine
Patient received the vaccine and was told to stay for 15 minutes  for observation. After 5 minutes the mother came with the son stating that he was not feeling well. He looked a bit pale and brought the patient back to the vaccination booth. I alerted management on duty .  The mother expressed that the soon was very nervous about getting the shots and tends to be nervous in general when it comes to getting shots. She stated that the doctor had suggested for him to put his head down when he gets that nervous.  The son put his head down between his knees and within 1 minute he stated that he felt better.  I gave him a cold pack which he put in his neck since he did not want to lay down.  I told them to stay a bit longer and observed him for additional 20minutes just to make sure he was doing ok.  I stayed with them to make sure that the pt was doing ok  and he was alert and just stated he was very nervous about getting the shot.  The stayed for at least 35minutes  and also management came to make a report of the incident.  I felt that the pt was nervous  but wanted to report it just in case.
PROVIDER PROGRESS NOTE 2/7/2022 Patient is a 66 y.o. female with history of hypertension, rheumatoid arthritis, unspecified interstitial lung disease not on home oxygen, who presented to the emergency room with complaints of cough, shortness of breath, diarrhea, vaccinated for COVID-19, with known exposure to COVID-19 and tested positive for COVID-19 today.   Acute hypoxic respiratory failure due to COVID-19 viral pneumonia -Symptoms started approximately 5 weeks ago and have progressively worsened.  Patient is fully vaccinated and has had her booster injection on 12/26/2021.  She is immunocompromised as she is on Rituxan for rheumatoid arthritis and her last infusion was in December 2021 -Full barrier precautions -Procalcitonin is 0.09, bacterial infection less likely and hence no indication for antibiotics -Encourage proning and I-S use -As needed antitussives -Oxygen to keep saturation more than 90%, wean as tolerated -Patient uses DuoNebs 3 times daily and she would like to continue that -Follow inflammatory markers, CRP is improving.  Continue Decadron 6 mg IV daily. -Lovenox 1 mg/kg subcu every 12 hours for D-dimer > 1.0 and for right lower extremity calf vein DVT. -Oxygen needs remain the same.  Patient given 1 dose of IV Lasix daily for 2 days, 02/05/2022 and 02/06/2022 -Appreciate pulmonology input -Discussed with patient that her symptoms could take weeks to resolve.  I did tell her there was an option to go home with oxygen and cough medication.  She will think about it.   Mild transaminitis -Likely due to COVID-19 -Follow periodically, improving   Hyponatremia -Likely due to poor oral intake, dehydration -Avoid maintenance IV fluids with COVID-19 infection, bolus fluids if needed -Sodium level has normalized   Hypertension -Hold PTA Cozaar and Norvasc because of borderline blood pressure.  Continue PTA Toprol-XL   Right calf DVT -Likely provoked given her COVID-19 infection and her inactivity because of her illness -No contraindication to anticoagulation -Continue Lovenox 1 mg/kg subcu every 12 hours per thromboprophylaxis protocol. Would probably treat for 3 months for calf vein DVT as she does not have any contraindication to anticoagulation. -Cost of Xarelto is $94 and Eliquis is $47.   Rheumatoid arthritis -Stable -Patient received Rituxan infusion in December 2021   Interstitial lung disease -Patient has interstitial lung disease related to her rheumatoid arthritis -She was not oxygen dependent  prior to admission -She follows with an outpatient pulmonologist -Appreciate pulmonology's input.  At this point would recommend that she follow-up with her outpatient pulmonologist.   Constipation -She is on scheduled MiraLAX -Add scheduled senna -Add as needed milk of magnesia   DVT Prophylaxis: On Lovenox 1 mg/kg subcu every 12 hours for right calf vein DVT and D-dimer > 1.0  Universal COVID-19 Screening:   SARS-CoV-2 RNA by PCR Date Value Ref Range Status 02/01/2022 SARS-CoV-2 RNA Detected (A) SARS-CoV-2 RNA Not Detected Final
This case was reported in a literature article and described the occurrence of anaphylaxis in a 5-year-old male subject who received DTaP-IPV vaccine. This case refers to patient 1 in the literature article. Co-suspect products included varicella vaccine and epinephrine. Concurrent medical conditions included fish allergy, peanut allergy and egg allergy. On an unknown date, several minutes after receiving DTaP-IPV vaccine, the subject developed anaphylaxis. Serious criteria included GSK medically significant and life threatening. Additional event(s) included general pruritus, wheezing, cough and vomiting. The subject was treated with epinephrine, antihistamine and antiemetic. The outcome of anaphylaxis was recovered/resolved. The outcome(s) of the additional event(s) included general pruritus (recovered/resolved), wheezing (recovered/resolved), cough (recovered/resolved) and vomiting (recovered/resolved). The investigator considered that there was a reasonable possibility that the anaphylaxis, general pruritus, wheezing, cough and vomiting may have been caused by DTaP-IPV vaccine. Additional information was provided: This case was reported in a literature article and it described the occurrence of a vaccine-triggered anaphylaxis in a 5-year-old male patient who had received an unspecified MMR vaccine (manufacturer unknown), an unspecified DTaP and IPV vaccine (manufacturer unknown) and an unspecified varicella vaccine (manufacturer unknown). The patient was a male. The subject's medical history included atopic disease with fish, peanuts and eggs allergies. No further information on the patient's concurrent medical conditions, medical or family history, or concomitant medication was provided. On an unspecified date, between the 1st of January of 2009 and the 31st of December of 2011, the patient received an unspecified dose of an unspecified MMR vaccine, an unspecified DTaP and IPV vaccine and an unspecified varicella vaccine (dosages unknown; administration routes and sites unspecified; batch numbers not provided). On an unspecified date, within less than 30 minutes after the vaccination, the patient developed general pruritus, wheeze, cough and vomiting. This was classified as anaphylaxis by the paediatrician. According to the authors the case was considered as Brighton level 2 and setting of initial evaluation was clinic. The patient was treated by epinephrine, oral antihistamine and antiemetic. At the time of reporting the outcome of the events was recovered. This event was classified as vaccine related according to the authors. The authors concluded that "Anaphylaxis after vaccination is rare in all age groups. Despite its rarity, anaphylaxis is a potentially life-threatening medical emergency that vaccine providers need to be prepared to treat. This case is 1 of the 28 valid cases reported in the same literature article.
Hay fever; soreness in joints; Nose is itching; Rash on right side of nose under eye/rash in face; sinuses; This is a spontaneous report from a contactable consumer or other non -health care professional (Patient). A 78-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), first dose via an unspecified route of administration, administered in Arm Left on 24Feb2021 14:00 (at the age of 78 years) as single for covid-19 immunization. Medical history included asthma (Asthma), seasonal allergy (Hay fever). The patient concomitant medications were not reported. On an unspecified date of 2021 the patient developed a reaction of pain in her joints. Had allergies like sinuses and hay fever for almost two days. She Had a rash in her face. Thursday started developing side effects like sinus or hay fever. Had it for two days. Then the side of her nose kept itching. she was looking in the glass and spotted a bump or a little rash on right side of her nose right under her eye. It is a round rash that is as big as her little fingernail. It is still there and plumped up and itching. There's one spot on top of her nose that is still itching. She had the allergy, sneezing, and blowing her nose. It was like sinus. It stopped because she took the Benadryl for that. Has been taking Tylenol 335mg for joint soreness. The Tylenol is slowing down the soreness in her joints. Benadryl has slowed down the allergy, itching, sneezing, and blowing her nose. Keeps drinking a lot of water. Every times she sneezes or blows her nose, she drink half a bottle of water. Itching and rash is still there now. Takes just one liqui-gel. Doesn't like taking too much of it. She was active and does exercising and doesn't want to be sleeping all of the time. May take one a day and that's it. Started Benadryl with just one, but her nose kept itching during the night so she would take another one. She takes one at night and one during the day. Now she was not taking any Benadryl because her allergy is gone. She was not blowing her nose. Nose it not itching. Still has the rash down the side of her face on top of her nose. Helped somewhat with the itching of her face. She had tried the cortisone 10 plus ultra moisturizing cream. It is good for itching and rashes. Benadryl helped somewhat with the itching on her face. Would take one Benadryl during the day, but then her nose kept itching at night so she would take another one. On an unspecified date of 2021 the outcome of the events hay fever, nose is itching, rash on right side of nose under eye/rash in face was unknown. The outcome of the event soreness was recovering. The outcome of the event sinuses was recovered on an unspecified date of 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
With a second Vaccine I took Zyrtec that morning. 1AM I had low grade fever and chills, in a morning woke up feeling okay and  forgot to take zyrtec. the third day after vaccine I develop rash on my neck, my arm was swollen ad I started to feel nauseous.  Nausea lasted for 10 days after the shot. The first few days were the worst I couldn't get up from bed it felt like I would faint if standing.
feeling fatigued; This is a spontaneous report received from a non-contactable consumer (patient).  A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, batch/lot number and Expiration date was not reported), via an unspecified route of administration, on 03feb2021, as a single dose for covid-19 immunisation. The patient medical history and concomitant medications was not reported. On 04Feb2021, the patient had reported feeling fatigued. Outcome of the event was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax 20FEB98 & on 11MAR98 pt devel 4-5papulovesicular lesions that were generalized w/h/a, malaise;pt was afeb;
Client states arm hurt when shot was given and continued to ache and in the following 2 weeks the painful area included her left shoulder and neck and whole left arm. She states the shoulder and neck pain stopped about 2 weeks ago, but the arm pain continues.  Also states it has affected her motor skills in left hand, as her fingers feel tingly and numb.
On 7-3-07 ran fever and on 7-4-07 broke out with a rash that started on face and trunk and spread. On 7-5-07 bumps was reported as more by Mom. He was advised to take Benadryl, Calamine lotion and Aveeno baths.
Rash all over the body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash all over the body) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced RASH (Rash all over the body). At the time of the report, RASH (Rash all over the body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included Benadryl, Cortisone Cream.
Breakthrough COVID first vaccine 1/9/2021 This is a pleasant  85-year-old male who was sent from hospital to the ED for swelling and redness of both legs. He had bil doppler studies yesterday which showed no DVT.   He has hx of DVT and is on eliquis. He denies dizziness, syncope, chest pain, shortness of breath, or palpitations. Patient has history of : Hypertension, Diabetes Mellitus, morbid obesity, CAD, CKD Hx of DVT on eliquis
Joint aches , fever 102.3 , vomiting everything I drank or ate and constant headache
Admission Date: 3/19/2023 Discharge Date: 3/20/2023   Clinical Narrative Patient is a 71 y.o. male patient who presented to the hospital 3/19/23 due to a generalized weakness and fall. Patient reports the day prior to admission he struggled to get out of his recliner when he went to bed. States when sitting at the edge of the bed he fell forward he did strike his head on the floor and developed a "rug burn".  He denies pain or trauma associated with this there was no loss of consciousness.  He wasn't able to get himself up from the restroom later that evening so he slept there. In the morning EMS was called when he still wasn't able to get up off the floor. He describes feeling weak was unable to get himself up. He did note some shaking chills. Denies any respiratory or GI symptoms. No sick contacts. He is vaccinated for covid and received 1 booster.    Workup unremarkable aside from elevated blood pressure, positive COVID 19 PCR and hematuria. Case was discussed with ER physician and observation monitoring was deemed appropriate due to high risk of decompensation with comorbidity of obesity, pre DM and OSA.  Pt admitted to observation and monitored overnight.   He felts significantly improved on day of discharge. He is able to ambulate around his room and sitting up in chair. He denies any fevers, chills, N/V, diarrhea, cough or URI symptoms. He does note some muscle soreness in his arms and shoulders he relates to trying to get himself up the days before.    His blood pressure was elevated throughout the admission thought to be secondary to viral illness and stress from hospitalization. He was encouraged to follow up with PCP regarding BP and hematuria.
p/vax rt arm sore; c/o fever, chills, body aches;arm w/ 11 x 6 1/2cm area w/induration;inc temp, erythema & tenderness;streaks of erythema;tx w/warm compress/Ibuprofen/Augmentin;
This spontaneous report as received from a certified medical assistant refers to multiple unspecified patients of unknown age and gender. Information regarding the patients medical history and current conditions were not provided. On an unknown date the patient was vaccinated with improperly stored doses of VARIVAX (Merck) lot # L026406, expiry date-15-JUL-2017. No adverse events were reported. No laboratory tests were reported. No product quality complaint (PQC) was involved. No further information was provided. This is one of the two reports from the same reporter. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Oct2022 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". Therapeutic measures were taken with Paxlovid from 13Mar2023 to 18Mar2023 as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
TINGLING SENSATION IN LIPS AND TOUNGE THE NEXT DAY AFTER THE VACCINE WAS RECEIVED. LOW GRADE FEVER AS WELL. EMESIS TOO.
Got covid positive a week later; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced got covid positive a week later on an unspecified date. Reported stated Got covid vaccine and got covid positive a week later. The patient underwent lab tests and procedures which included sars-cov-2 test: positive an unspecified date. The event got covid positive a week later was non-serious. The outcome of the event got covid positive a week later was unknown.  Information on the lot/batch number has been requested.